U.S. state-level variation in caregiver-reported provider recommendation of HPV vaccination to 13-to-17-year-old adolescents
Cancer Causes & Control · 2026-12 · 37 (12)
DOI: 10.1007/s10552-026-02283-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Causes & Control, online erschienen am 12.11.2026. Verfasst von Chinenye Lynette Ejezie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Towson University, 8000 York Road, Towson, MD, 21252, USA. cejezie@towson.edu. Hauptthemen laut MEDLINE: Papillomavirus Vaccines, Papillomavirus Infections, Caregivers, Vaccination. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Although regional differences in provider recommendation of human papillomavirus (HPV) vaccine have been documented, limited research has examined variation at the state level. Therefore, this study examined state-level differences in caregiver-reported health care provider recommendation of HPV vaccines among 13-to-17-year-old adolescents in the United States.
Method
Using a cross-sectional design to examine data from the National Immunization Survey–Teen (2023), multivariable logistic regression was used to model state-specific variations in provider recommendation of HPV vaccine. Proportion estimation was used to examine state-specific prevalence.
Result
Provider recommendation varied considerably across states. For example, the odds of reporting a recommendation were lower among caregivers of adolescents in Arkansas (adjusted odds ratio [AOR] = 0.56, 95% confidence interval [CI] = 0.33 to 0.96), Georgia (AOR = 0.49, 95% CI = 0.26 to 0.93), and Mississippi (AOR = 0.42, 95% CI = 0.24 to 0.74), and higher among caregivers in New Hampshire (AOR = 2.40, 95% CI = 1.23 to 4.68) compared with adolescents in California. Greater heterogeneity was observed in the South compared with other regions. For example, the prevalence of not receiving a recommendation was 16% in Maryland and 41% in Mississippi.
Conclusion
The findings underscore the need to improve HPV vaccine recommendation in some states in the United States. In particular, states with low rates should be targeted for focused interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Towson University, 8000 York Road, Towson, MD, 21252, USA. cejezie@towson.edu.
- Towson University, 8000 York Road, Towson, MD, 21252, USA.
- Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, 33431, USA.
- UTHealth Houston School of Public Health, 1930 Old Spanish Trail, Houston, TX, 77054, USA.
Zitieren
APA
Ejezie, C. L., Zhang, C., Eldawy, N., Li, M., & Cuccaro, P. (2026). U.S. state-level variation in caregiver-reported provider recommendation of HPV vaccination to 13-to-17-year-old adolescents. Cancer Causes & Control, 37(12). https://doi.org/10.1007/s10552-026-02283-5
Vancouver
Ejezie CL, Zhang C, Eldawy N, Li M, Cuccaro P. U.S. state-level variation in caregiver-reported provider recommendation of HPV vaccination to 13-to-17-year-old adolescents. Cancer Causes & Control. 2026;37(12). doi:10.1007/s10552-026-02283-5
BibTeX
@article{Ejezie2026,
author = {Ejezie, Chinenye Lynette and Zhang, Chengcheng and Eldawy, Nada and Li, Ming and Cuccaro, Paula},
title = {U.S. state-level variation in caregiver-reported provider recommendation of HPV vaccination to 13-to-17-year-old adolescents},
journal = {Cancer Causes & Control},
year = {2026},
volume = {37},
number = {12},
doi = {10.1007/s10552-026-02283-5}
}
EUVIMED